Objective To investigate the role of human leukocyte antigen (HLA) genes among Filipino patients of varying ages with spondyloarthropathies compared to healthy controls in a tertiary center. Methods This is a case-control study where the index patient is matched by a related and unrelated control. HLA-B27 and HLA-DRB1 genotyping were performed via polymerase chain reactions using sequence-specifi c primers.
INTRODUCTION AND REVIEW OF LITERATURE
Spondyloarthropathy (SpA) is a family of interrelated conditions that share common clinical (sacroiliitis) and genetic characteristics (HLA-B27) that clearly differentiates it from rheumatoid arthritis and other infl ammatory arthritis.
The risk for AS is 16 times higher among HLA-B27 positive relatives than HLA-B27 positive individuals from the general population (1) . First-, second-, and third-degree relatives of patients with AS have markedly increased risks of developing the disease (relative risks of 94, 25, and 4, respectively) (2). However, HLA-B27 contributes to only 50% of the total genetic risk of individuals. Studies on AS suggest that additional genetic factors, distinct from the HLA region, are involved. HLA-DR4 contributes significantly to the genetic predisposition to SpA among French families (3) . There was a signifi cant association of HLA-DR1 and HLA-B15 with SpA in Mexicans independent of B27 (4). The expression of these genes varied with different forms of SpA.
HLA-B27 Subtypes and SpA Association
More than 27 molecular subtypes of HLA-B27 have been described thus far. HLA-B*2705 is the most widespread HLA-B27 subtype and is clearly associated with AS and related SpAs around the world, except among the West African population of Senegal and Gambia. It is virtually the only observed subtype among the native populations of Eastern Siberia and North America and is present in approximately 90% of the B27 positive individuals of northern European extraction. HLA-B*2704 is the predominant subtype among the Chinese and Japanese and is strongly associated with SpA. In Thailand, B*2704 and B*2706 are equally prevalent, whereas in Indonesia B*2706 is the predominant subtype (5, 6) .
However, associations with AS appear to differ between subtypes and seemingly between populations as well. Haplotype studies that investigated HLA-B27 interaction with other alleles indicate a subtype-specifi c AS association for the B*2704 and B*2705 alleles, but not for B*2706 and B*2709 (7, 8) . A study done on Taiwan Chinese, however, suggests a protective role for B*2705 (9) .
Genotyping has been helpful in identifying more patients with the disease and also for recognizing the disease very early. Axial SpA has typically gone undetected until much later in the course of the disease. People with the HLA-B27 genotype have been found to be most susceptible in developing axial SpA.
HLA-DRB1
Despite the established role that HLA-B27 plays in the development of seronegative SpAs, family and twin studies suggest that additional genetic factors may also be involved. Studies on the Caucasian populations suggest DRB1*0401 may be associated with AS in Scots, but no association was found between DRB1*01 or *04 with AS or reactive arthritis in Finns. The DRB1*0408-DQB1*0301 haplotype instead, was noted in HLA-B27-positive Finns suffering from reactive arthritis (10) . In Tunisians, a higher frequency of DRB1*15 was found in AS patients, and DRB1*04 in reactive arthritis patients, as compared to healthy controls (11) . On the other hand, a study by Komata et al. involving HLA-B27 positive Japanese individuals suggest a linkage disequilibrium between HLA-B27*05 and DRB1*0101 indicating HLA-DRB1 alleles encoding a shared epitope associated with rheumatoid arthritis that may act as an additional susceptibility factor for developing SpA in these individuals (12) .
OBJECTIVES
The general objective of this study is to investigate the role of HLA genes among Filipino patients of varying ages with SpAs compared to healthy controls seen at the University of Santo Tomas Hospital. The specifi c objectives are to investigate whether HLA-B27 is associated with SpA and whether other MHC alleles i.e., HLA-DRB1 is associated with risk for SpAs and severity of disease with HLA genotype.
METHODS

Subjects
This is a case-control study whereby the index patient was matched with both a related and an unrelated control. Demographic profi le including serum HLA-B27 positivity, axial and/or peripheral joint involvement, extra-articular features, sacroiliitis, and diagnostics (radiograph/MRI fi ndings) were gathered when available in addition to the physical examination.
Genetic Analysis
Genomic DNA from both cases and controls (related and unrelated) were extracted from 4 ml whole blood containing EDTA by standard techniques for HLA typing in the Molecular Genetics Laboratory of the Institute of Human Genetics, National Institutes of Health, University of the Philippines. HLA-B27 and HLA-DRB1 genotyping were also performed via polymerase chain reaction using sequence-specifi c primers. Genotyping for 18 HLA-DRB1 alleles were done via nested PCR amplifi cation. PCR products were separated via electrophoresis in 2% agarose and visualized using GelRed nucleic acid stain and UV transillumination.
Statistical Analysis
The McNemar test was used to test the equality of proportions between the two paired groups. Equality of odds ratios across age groups was tested using the Breslow-Day test. The magnitude of association was expressed as odds ratio (OR) with corresponding confi dence intervals. The level of signifi cance was set at p = 0.05.
Ethical Review
The study protocol was reviewed and approved by the independent Institutional Review Board of the University of Santo Tomas Hospital in accordance with the Declaration of Helsinki and the International Conference on Harmonization/Good Clinical Practice. Table 2) . Twenty percent (13/47) of patients and their related controls were B27 positive, 19% (9/47) of them were B27+ but B27-related controls, 53% (25/47) of both patients and controls were B27- (Table 3) . Among the clinical presentations of SA, HLA-B27 was signifi cantly associated with axial involvement (OR = 14, 95%CI 3.38, 58.07) and bilateral sacroiliitis (OR = 16.61, 95%CI 3.11, 88.8), but not with peripheral joint involvement (OR = 0.125, 95%CI 0.032, 0.485), with p<0.05. However, B27 did not have a signifi cant association with clinical features like shoulder, knee, feet, hand, hip, elbow, and low back pain and uveitis (p>0.05). Bilateral sacroiliitis was seen in 15 patients (31.9%), 14 of whom had AS and 1 PsA.
RESULTS
Forty
HLA-DRB1 genotype
Of the 94 HLA-DRB1 alleles identifi ed in patients, 25% had DRB1*15, 12% each for *04 and *12, 10% had *0901 while the rest had *08, *1401, *1001, *11, *0701, *16, and *13. No pattern of DRB1 alleles was found to be signifi cantly associated with any of the SpAs.
There were three patients with no identifi ed similar HLA-DRB1 allele with their related controls. Of the 9 patients with exactly the same pair of HLA-DRB1 alleles, 7 were siblings, while 2 were parent and daughter of the index patient. Seventy-four percent of the patients had at least 1 similar HLA-DRB1 allele with their related control.
An exploratory analysis was done on whether HLA-DRB1 gene acts as an additional susceptibility to HLA-B27 positive individuals. However, due to the huge diversity of HLA-DRB1 alleles identifi ed, a statistical analysis could not be deduced from the data.
Ankylosing spondylitis (AS)
Of the 89.5% (17/19) AS patients who are HLA-B27 positive, 94% (16/17) had axial symptoms, 82% (14/17) had bilateral, while 18% (3/17) had unilateral sacroiliitis, and 16% (3/19) had uveitis. Five patients presented with a bamboo spine that contributed signifi cantly to their limited spine mobility. Two patients developed psoriasis, one 5 years after the onset of juvenile AS, while the other patient developed psoriatic skin lesions 2 years after signifi cant spine immobility.
Psoriatic arthritis (PsA)
Mean age of onset of symptoms is much older in patients with PsA compared to AS (40.24 yrs in PsA vs 28.28 yrs in AS). A majority of the patients (20/25) had the peripheral joint more than axial spine (5/25) involvement. There were 4 patients who were HLA-B27+, 2 of whom had prominent axial involvement. However, 3 patients with axial involvement were HLA-B27-. Three patients with signifi cant disability -blindness, hand joint deformity, and limited spine mobility, wheelchair-borne -were all HLA-B27-. (15) . These patients are associated with a younger age at onset of infl ammatory back pain, less delay in diagnosis, lower frequency of psoriasis, and higher frequency of MRI infl ammation of the sacroiliac joints. Our study similarly showed a little more than half (9/17) of AS participants who are HLA-B27+ and had their disease onset at <30 years of age. Uveitis as an extra-articular manifestation of AS had been reported to occur between 20-30% in a selected population (16) compared to 16% in our study.
Further to the HLA-B27 gene polymorphism, HLA-B*2701 to HLA-B*2723, Zhen Wu et al. (17) was able to identify B*2704 as the predominant subtype in AS of Han Chinese descent followed by B*2705. HLAB*2715, albeit a rare subtype of the B27 allele, is detected almost only in patients with AS. Of the more than 20 subtypes, *2706 and *2709 are not associated with AS. However, the clinical relevance of the presence of both subtypes in AS is not known.
HLA-B22 was found to be protective in PsA while HLA-B27 in the presence of DR-7, B39, and DQw3 in the absence of DR7 were predictive of subsequent damage (18) . In another study, psoriasis and PsA have been associated with HLA antigens B13, B16 (B38, B39), B57, Cw6, and DR7 (19) . The frequency of HLA-DRB1*0402 was found to be higher in PsA compared to HLA-DRB1*0401, which was more frequently seen in rheumatoid arthritis patients and controls. Differences in class II HLA epitope in the presence of putative arthritogenic antigen and disease expression remains to be extensively studied (20) .
In summary, we did the fi rst study on genetic polymorphism among Filipino patients with SpA. HLA-B27 is found to be strongly associated with AS and similarly reported elsewhere. However, there was no pattern of association of HLA-DRB1 alleles identifi ed in our patients. Further studies are needed to explore the contribution of genetic susceptibility of HLA-B27 genes as well as other genetic markers in detail to clinical disease expression in these patients.
